DAPA POWER 10mg (Dapagliflozin Tablet) 10mg

DAPA POWER 10mg (Dapagliflozin) tablets are prescribed for type 2 diabetes management. This oral medication helps regulate blood sugar levels when combined with diet and exercise. Dapagliflozin belongs to the SGLT2 inhibitor class, supporting kidney function in glucose regulation.

Strength

10mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

GNH India Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dapagliflozin 10mg tablets are used to improve blood sugar control in adults with type 2 diabetes. It works by helping the kidneys remove excess glucose through urine, reducing blood sugar levels. This medication is often prescribed alongside diet and exercise for better results. It may also be used in combination with other diabetes medications.

Side Effects

Users may experience increased urination as the body removes extra glucose. Some people notice changes in thirst or appetite due to improved blood sugar levels. Dapagliflozin may also lead to mild weight loss over time as excess glucose is excreted. These effects are generally part of the medication's mechanism of action.

Precautions & Warnings

Keep DAPA POWER 10mg tablets at room temperature away from moisture and heat. Store in a secure place out of reach of children and pets. Avoid crushing or splitting tablets unless advised by a healthcare professional. Report any unusual symptoms to a doctor promptly.

Avoid Interactions

Dapagliflozin may interact with diuretics, insulin, or other diabetes medications, potentially increasing the risk of low blood sugar. Alcohol use can affect blood sugar levels and may worsen side effects. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Dapagliflozin 10mg is used to help manage type 2 diabetes by improving blood sugar control.

Store DAPA POWER 10mg tablets at room temperature in a dry place away from direct sunlight.

Dapagliflozin alone rarely causes low blood sugar, but it may increase the risk when combined with other diabetes medications.

Common side effects include increased urination, thirst, and mild weight loss.

Consult a healthcare provider to determine if Dapagliflozin is suitable for your condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.